Filing metadata

Accession number
0001209191-24-000255
Form type
Form 4
Filer
Enliven Therapeutics, Inc.
CIK
CIK 1672619
Filed
Jan 02, 2024
Reporting period
Dec 28, 2023
Description
Insider transaction

Explore SEC Filings Hub